Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04373109
Other study ID # BASEC-Nr. 2020-00761
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 16, 2020
Est. completion date October 12, 2020

Study information

Verified date October 2020
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

COVID-19 has a big impact on individuals and society as a whole. Especially persons with (multiple) comorbidities such as stroke are affected. The impact of COVID-19 on stroke rehabilitation delivery and stroke patients' functioning is unclear.


Description:

With 16'000 patients hospitalized and with new permanent disability in approximately 7'000 individuals every year in Switzerland, stroke has a major impact on quality of life and is an enormous socioeconomic burden. Virtually all patients receive inpatient rehabilitation in the sub-acute phase poststroke. However, also in the later phases poststroke, patients receive rehabilitation interventions in outpatient rehabilitation clinics and private practices, with goal to improve or maintain their functional capacity. Currently, Switzerland finds itself in an extraordinary situation. The Federal Council has issued a series of measures aimed at the population, organizations and institutions, and the cantons. The aim is to curb the spread of the coronavirus and assure the provision of healthcare. The people are invoked to stay at home and only leave the home if absolutely necessary. If they are over the age of 65 or have an underlying medical condition, the Federal Council strongly recommend that you stay at home under any circumstances unless you have to go to the doctor. With the recommendation of the Swiss Federal Council almost all stroke patients belong to the group who should stay home. Furthermore, all outpatient rehabilitation clinics have reduced the interventions to a minimum. It is unknown how a sudden stop of rehabilitation influences the stroke patients' functional capacities and their perceived quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date October 12, 2020
Est. primary completion date October 12, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Ischemic or haemorrhagic stroke, confirmed by MRI-DWI and/or CT - Participating in a stroke research project before the Lockdown (ESTREL - BASEC Nr. 2018-02021/ RE-USE - BASEC-Nr. 2017-01070) - Age 18 years or older - Verbal and written informed consent of the patient after participants' information Exclusion Criteria: - Severe communication or cognitive deficits, that cause inability to follow the procedures

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Observation
Observation of intensity of rehabilitation therapy, daily life upper limb use, physical activi-ty engagement, patient-reported quality of life, and motor outcome after stroke

Locations

Country Name City State
Switzerland University Hospital Zurich Zurich

Sponsors (1)

Lead Sponsor Collaborator
Jeremia Held

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rehabilitation data Nature of rehabilitation therapy, and number and duration of rehabilitation therapy sessions 3 month after start lockdown
Primary Motor Activity Log - 14 Item Version Patient-reported upper limb use in daily life 3 month after start lockdown
Primary International Physical Activity Questionnaire Patient-reported engagement in physical activity in daily life 3 month after start lockdown
Primary Patient-Reported Outcomes Measurement Information System - 29 Version Patient-self-assessment comprising the following categories: 1) physical function, 2) anxiety, 3) depression, 4) fatigue, 5) sleep disturbance, 6) ability to participate in social roles and activities, 7) pain interference and 8) pain intensity 3 month after start lockdown
Secondary Global Rating of Perceived Changes (physical activity engagement and upper limb use) Patient-reported global rating of physical activity engagement and upper limb use in daily life 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Fatigue Severity Scale Self-reported questionnaire regarding severity of fatigue and its influence on the performance of daily life activities 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Hospital Anxiety and Depression Scale Depression and anxiety 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Montreal Cognitive Assessment Assesses cognitive functions 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Functional Ambulation Categories Classification regarding the ability to walk independently, with or without a walking aid and takes the type of walking surface into account 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Ten-Meter Walk Test Gait speed and cadence 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Rivermead Mobility Index Measures the ability of patients to make postural adjustments (e.g, move in bed), transfer (e.g. be-tween bed to chair), walk, and use stairs 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Activities-specific Balance Confidence Scale Self-reported measure in which patients rate how confident they are in maintaining balance when performing 16 daily life tasks 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Fugl-Meyer Motor Assessment Upper and lower limb motor function 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Action Research Arm Test Upper limb capacity 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary modified Rankin Scale Global disability 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary National Institutes of Health Stroke Scale Neurological impairments 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 3 months after lockdown, 6 months after lockdown
Secondary Rehabilitation data Nature of rehabilitation therapy, and number and duration of rehabilitation therapy sessions 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
Secondary Motor Activity Log - 14 Item Version Patient-reported upper limb use in daily life 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
Secondary International Physical Activity Questionnaire Patient-reported engagement in physical activity in daily life 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
Secondary Patient-Reported Outcomes Measurement Information System - 29 Version Patient-self-assessment comprising the following categories: 1) physical function, 2) anxiety, 3) depression, 4) fatigue, 5) sleep disturbance, 6) ability to participate in social roles and activities, 7) pain interference and 8) pain intensity 4 weeks after lockdown ("extraordinary situation" as defined by the Swiss law), 6 months after lockdown
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Enrolling by invitation NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis